# Editorial: Combinational therapy and nanotechnologies in combating pathogenic microbes and antibiotic resistance

**Authors:** Kwang-sun Kim

PMC · DOI: 10.3389/fphar.2024.1406043 · Frontiers in Pharmacology · 2024-05-07

## Full-text entities

- **Diseases:** bacterial infections (MESH:D001424), deaths (MESH:D003643), urinary, pneumonia, and bloodstream infections (MESH:D018805), MTB infections (MESH:D014376), MDR (MESH:D018088), toxicity (MESH:D064420), resistance (MESH:D060467), nosocomial infections (MESH:D003428), Gram-negative bacterial infections (MESH:D016905), critically ill (MESH:D016638)
- **Chemicals:** INH (MESH:D007538), aminoglycosides (MESH:D000617), polymers (MESH:D011108), graphene (MESH:D006108), quinolones (MESH:D015363), beta-lactams (MESH:D047090), chitosan (MESH:D048271), metal (MESH:D008670), titanium (MESH:D014025), fluoroquinolones (MESH:D024841), carbon nanotubes (MESH:D037742), Carbapenem (MESH:D015780), ROS (-), meropenem (MESH:D000077731), glycerophospholipids (MESH:D020404), GSH (MESH:D005978)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mycobacterium tuberculosis (species) [taxon 1773], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11106493/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11106493/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC11106493/full.md

---
Source: https://tomesphere.com/paper/PMC11106493